PFIZER LIMITED header image

PFIZER LIMITED

500680

Equity

ISIN INE182A01018 / Valor 912046

Bombay Stock Exchange Ltd. (Mumbai) (2026-11-09)
INR 3,919.45+1.77%

PFIZER LIMITED
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Pfizer Limited is the local operating arm of Pfizer Inc., functioning as a manufacturer, marketer and distributor of prescription medicines and vaccines while supporting clinical research and regulatory activities in its market. The company commercializes treatments across a range of therapeutic areas — notably oncology, vaccines (including its COVID‑19 mRNA vaccine developed with BioNTech), internal medicine, inflammation and immunology, and rare diseases — and works with hospitals, clinics, pharmacies and government programs to supply products and run clinical trials. Its business model combines in‑house and partnered R&D, manufacturing and licensing arrangements to bring patented branded therapies to market, generate revenue through product sales and secured procurement contracts, and manage the regulatory and reimbursement processes that determine market access.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-22.7%1Y
0.93%3Y
-25.2%5Y

Performance

23.8%1Y
26.2%3Y
23.6%5Y

Volatility

Market cap

1920 M

Market cap (USD)

Daily traded volume (Shares)

29,618

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.52%GBP 16.25
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%GBP 0.63
Almirall SA
Almirall SA Almirall SA Valor: 3180354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.42%EUR 10.50
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.06%EUR 67.40
Galderma Group Ltd
Galderma Group Ltd Galderma Group Ltd Valor: 133539272
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%CHF 190.65
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.12%EUR 10.85
BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%CHF 22.50
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.32%SEK 496.60
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%INR 581.80
Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.61%SEK 127.10